oral semaglutide approval Drug Watch: The version of is now approved for weight reduction, with a maintenance dose of 25 mg daily. "For patients paying for the oral option out of pocket, the US FDA accepts Novo Nordisk's

Additionally, weight loss may plateau after a certain point, and it is important for patients to continue to follow a healthy diet and exercise program in order to maintain their weight loss over time

This means youll gradually increase your dose each month (if suitable) to give your body time to adjust and reduce any potential side effects

KFF survey also reported that about half of adults who have taken GLP-1s say it was difficult to afford the cost of these drugs that come with a hefty price tag of about $1000 U.S

have existing health conditions

Ozempic is a specific brand of GLP-1 receptor agonist designed for managing type 2 diabetes and, in some cases, aiding in weight loss